U.S. economic turmoil and shifting federal policies in 2025 may threaten COVID-19 funding, surveillance, and vaccine access. Learn what’s at stake at home and abroad.
Currently browsing: Future
ASSURE In the News
Anti-Vaccine Sentiment Threatens Future FDA Vaccine Approvals
Concerns rise as anti-vaccine views in government threaten the approval process for new vaccines awaiting FDA and regulatory review in 2025.
Assessing Future Pandemic Risks and Global Preparedness in 2025
An analysis of the probability of future pandemics, current preparedness levels, and the influence of globalization on disease spread as of 2025.
Could New US Tariffs Impact COVID-19 Measures?
Explore whether the new US tariffs could affect COVID-19 response and supply chains, and if lingering pandemic effects may shape tariff policies in 2025.
Novavax Delay & RFK Jr.’s Vaccine Misinformation in 2025
Explore the latest on the Novavax COVID-19 vaccine delay and RFK Jr.’s false claims about vaccine safety, with facts from experts and public health agencies.
What March 2025 COVID Funding Cuts Mean for Americans
Discover how recent March 2025 federal cuts to COVID-19 funding impact local health departments, testing access, and pandemic preparedness across the U.S.
Comprehensive Overview of Circulating COVID-19 Variants in 2025: Symptoms and Characteristics
Explore a comprehensive overview of the currently-circulating COVID-19 variants in 2025, and their symptoms and characteristics
COVID-19 Quarantine Guidance for March-April 2025: How Long to Stay Home
Stay updated with the latest CDC guidance on COVID-19 quarantine and isolation for March-April 2025. Learn when and how long to stay home if you test positive.
Comprehensive Strategies to Protect Your Family from COVID-19 and Seasonal Viruses
Learn effective measures, including vaccinations, hygiene practices, and rapid testing, to safeguard your family against COVID-19, flu, and RSV.
Ensitrelvir: A Promising Antiviral for Preventing Household COVID-19 Transmission
Explore how ensitrelvir, an oral antiviral, effectively reduces COVID-19 transmission within households through recent clinical trials.